Therapy for acute heart failure syndromes

被引：5

作者：

Donlan S.M. ^{[1
]}

Quattromani E. ^{[1
]}

Pang P.S. ^{[1
]}

Gheorghiade M. ^{[1
]}

机构：

[1] Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, IL 60611

来源：

Current Cardiology Reports | 2009年 / 11卷 / 3期

关键词：

Chronic Heart Failure; Dobutamine; Acute Heart Failure; Milrinone; Decompensated Heart Failure;

D O I：

10.1007/s11886-009-0028-6

中图分类号：

学科分类号：

摘要：

The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data. © Current Medicine Group, LLC 2009.

引用

页码：192 / 201

页数：9

共 50 条

[21] In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure
Zhang, Hanfei
Goodman, Shaun G.
Yan, Raymond T.
Steg, Ph Gabriel
Kornder, Jan M.
Gyenes, Gabor T.
Grondin, Francois R.
Brieger, David
DeYoung, J. Paul
Gallo, Richard
Yan, Andrew T.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (03) : 214 - 222
[22] A Review of Phase II Acute Heart Failure Syndromes Clinical Trials
Pang, Peter S.
Gheorghiade, Mihai
HEART FAILURE CLINICS, 2011, 7 (04) : 441 - +
[23] Is There a Rationale for Antiplatelet Therapy in Acute Heart Failure
Mentz, Robert J.
Lazzarini, Valentina
Fiuzat, Mona
Metra, Marco
O'Connor, Christopher M.
Felker, G. Michael
CIRCULATION-HEART FAILURE, 2013, 6 (04) : 869 - 876
[24] Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure
Arnold, Lindsay M.
Crouch, Michael A.
Carroll, Norman V.
Oinonen, Michael J.
PHARMACOTHERAPY, 2006, 26 (08): : 1078 - 1085
[25] Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
Harjola, Veli-Pekka
Parissis, John
Bauersachs, Johann
Brunner-La Rocca, Hans-Peter
Bueno, Hector
Celutkiene, Jelena
Chioncel, Ovidiu
Coats, Andrew J. S.
Collins, Sean P.
de Boer, Rudolf A.
Filippatos, Gerasimos
Gayat, Etienne
Hill, Loreena
Laine, Mika
Lassus, Johan
Lommi, Jyri
Masip, Josep
Mebazaa, Alexandre
Metra, Marco
Miro, Oscar
Mortara, Andrea
Mueller, Christian
Mullens, Wilfried
Peacock, W. Frank
Pentikaeinen, Markku
Piepoli, Massimo F.
Polyzogopoulou, Effie
Rudiger, Alain
Ruschitzka, Frank
Seferovic, Petar
Sionis, Alessandro
Teerlink, John R.
Thum, Thomas
Varpula, Marjut
Weinstein, Jean Marc
Yilmaz, Mehmet B.
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (08) : 1298 - 1314
[26] Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes
Lazzeri, Chiara
Valente, Serafina
Attana, Paola
Chiostri, Marco
Picariello, Claudio
Gensini, Gian Franco
INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (06) : 497 - 503
[27] Acute Heart Failure With and Without Concomitant Acute Coronary Syndromes: Patient Characteristics, Management, and Survival
Tarvasmaki, Tuukka
Harjola, Veli-Pekka
Nieminen, Markku S.
Siirila-Waris, Krista
Tolonen, Jukka
Tolppanen, Heli
Lassus, Johan
JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : 723 - 730
[28] Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes
Chiara Lazzeri
Serafina Valente
Paola Attanà
Marco Chiostri
Claudio Picariello
Gian Franco Gensini
Internal and Emergency Medicine, 2012, 7 : 497 - 503
[29] Considerations for initial therapy in the treatment of acute heart failure
William F. Peacock
Chad M. Cannon
Adam J. Singer
Brian C. Hiestand
Critical Care, 19
[30] Treatment of acute heart failure
Simonis, Gregor
Spitzer, Stefan G.
Stumpf, Juergen
Doerr, Rolf
HERZ, 2015, 40 (05) : 823 - 831

← 1 2 3 4 5 →